trending Market Intelligence /marketintelligence/en/news-insights/trending/jb6rgxuoxfeg50pms54hrg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

NY to end pre-authorization requirement for substance use disorder treatment

Brazil Pay TV Down Record Amount In 2019, With Losses Continuing In Q1'20

Impact of COVID 19 on US Video Entertainment Trends

Case Study: Transforming Sales Enablement Data at a Global Advertising and Media Firm

Key Credit Risk Factors When Assessing Banks In The Context Of COVID-19

NY to end pre-authorization requirement for substance use disorder treatment

New health insurance reforms that will allow immediate access to inpatient treatment and medications for substance use disorders will go into effect in New York on Jan. 1, 2017, Gov. Andrew Cuomo said in a statement.

The reforms require insurers to end the prior authorization requirement for inpatient treatment of substance use disorders for as long as needed. In addition, insurers will be prohibited from requiring prior approval for emergency supplies of drug treatment medications.

The new coverage requirements apply to individual plans as well as small and large group plans regulated by the New York Department of Financial Services that will be issued or renewed Jan. 1, 2017.